Stock Analiz

LLY vs MRK stock comparison

ELI LILLY & Co vs. Merck & Co. · data as of November 13, 2026

ELI LILLY & Co (LLY) has a market value of about $1.36T, Merck & Co. (MRK) about $364.3B. Over their latest twelve months ELI LILLY & Co had revenue of $86.5B and Merck & Co. $67.4B.

On our five checks ELI LILLY & Co scores higher: 3.4 out of 5 (good) against 2.8 (average).

By area, the stronger company is ELI LILLY & Co on future growth; ELI LILLY & Co on financial health; Merck & Co. on shareholder returns.

ELI LILLY & Co is cheaper on earnings (P/E 46.9 vs. 150.8).

ELI LILLY & Co leads on 13 of the compared lines and Merck & Co. on 10.

Side by side

LLYMRK
Size and price
Market cap$1.36T$364.3B
Share price$1,443.50$147.76
Score
Overall score (of 5)3.42.8
Value00
Future growth52
Track record55
Financial health32
Shareholder returns45
Valuation
P/E (TTM)46.9150.8
Forward P/E30.417.6
Price / free cash flow69.124.7
Price / sales15.75.4
EV / EBITDA37.132.5
PEG1.707.10
DCF value vs. price−37%−31%
Business
Revenue$86.5B$67.4B
Net income$27.6B$2.5B
Free cash flow$19.7B$14.7B
Net margin31.9%3.6%
Gross margin (5-yr avg.)78.9%73.4%
ROIC (5-yr avg.)22.9%16.3%
Growth
Revenue growth (1 yr)44.7%1.3%
Revenue growth (5 yrs, per year)21.6%9.4%
EPS growth (5 yrs, per year)27.6%21.2%
Balance sheet and payouts
Net cash (cash minus debt)-$44.6B-$44.1B
Dividend yield0.48%2.30%
Shareholder yield0.8%3.7%
Analysts
Upside to average target+1%+9%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: LLY TTM to September 30, 2026, MRK TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, ELI LILLY & Co or Merck & Co.?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) ELI LILLY & Co scores 3.4 out of 5 and Merck & Co. 2.8; the table shows where each one is stronger.

Is ELI LILLY & Co cheaper than Merck & Co.?

On trailing earnings, ELI LILLY & Co trades at a P/E of 46.9 and Merck & Co. at 150.8, so ELI LILLY & Co is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, ELI LILLY & Co or Merck & Co.?

Over five years ELI LILLY & Co grew revenue about 21.6% a year and Merck & Co. about 9.4% a year.

Which pays a higher dividend?

ELI LILLY & Co yields 0.48% and Merck & Co. 2.30%.

Full ELI LILLY & Co analysis → Full Merck & Co. analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.